Mösges R, Schmalz P, Köberlein J, Kaciran M, Baiardini I
Institut für Medizinische Statistik, Informatik und Epidemiologie der Universität zu Köln.
HNO. 2007 May;55(5):357-64. doi: 10.1007/s00106-006-1453-0.
In 2003 Baiardini et al. presented the RHINASTHMA questionnaire, which measures the impairment of quality of life in patients with rhinitis and asthma and takes the "united airway disease" model into its account. The aim of our study was to create a valid version of this questionnaire adapted for use with German-speaking subjects.
Datasets recorded for 85 patients were analysed for sensitivity, reliability and validity of the new questionnaire. For this purpose, as well as the symptom scores, disease-specific and generic quality of life questionnaires were also used as a measure of validity.
A correlation analysis and Cronbach's alpha indicated that the RHINASTHMA scale is satisfactory from the aspect of reliability. Good validity was also shown in terms of discrimination and agreement for all items and scores. In addition, all the observed parameters reacted sensitively to clinical improvements of the health status.
The RHINASTHMA questionnaire makes it possible to determine how badly the quality of life is impaired by rhinitis and asthma, based on the paradigm of "united airway disease".
2003年,拜亚尔迪尼等人提出了“鼻哮喘问卷”,该问卷用于衡量鼻炎和哮喘患者的生活质量受损情况,并考虑了“联合气道疾病”模型。我们研究的目的是创建一个适用于德语使用者的该问卷有效版本。
分析了为85名患者记录的数据集,以评估新问卷的敏感性、可靠性和有效性。为此,除了症状评分外,还使用了疾病特异性和通用生活质量问卷作为有效性的衡量指标。
相关性分析和克朗巴哈系数表明,从可靠性方面来看,“鼻哮喘量表”令人满意。在所有项目和评分的区分度和一致性方面也显示出良好的有效性。此外,所有观察到的参数对健康状况的临床改善都有敏感反应。
“鼻哮喘问卷”使我们能够基于“联合气道疾病”范式确定鼻炎和哮喘对生活质量的损害程度。